Hologic (HOLX)
Hologic Capital Expenditures: 6.381M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
HOLX Capital Expenditures Rankings
| Overall | 36th percentile | 2803 of 4449 |
| Sector | 21st percentile | 397 of 507 in Healthcare |
| Industry | 26th percentile | 56 of 76 in Medical Appliances & Equipment |
HOLX Capital Expenditures Range, Past 5 Years
| Minimum | 2.102M | Mar 2011 |
| Maximum | 85.06M | Sep 2010 |
| Average | 17.93M |
About Capex
Capital expenditures are a line item from a company's statement of cash flows (click "Learn More" below for details).
Capex (short for capital expenditures) are incurred when a business spends money to purchase fixed assets or to add value to an existing fixed asset. In accounting, a capital expenditures are added to an asset account, thus increasing the value of the asset.
Examples of capital expenditures include the purchase of a new manufacturing plant, investment in server farms for tech companies, or other purchases of assets expected to help the company earn profits in the future.
Unlike other investments like research and development and marketing spending, capital expenditures are not immediately expensed. Rather, property, plant and equipment acquired using capital expenditures are usually expensed over time through the use of depreciation.
Learn More
You may also be interested in these HOLX related companies
HOLX News
Conditions of Growth, Economic Analysis - Research Report on SINA Corporation (USA) and Hologic, Inc.
May 25, 9:00AM Marketwire
May 25, 9:00AM Marketwire
Video of tomorrow's setups on $FWLT $ARUN $HOLX $ACI $HUN $WPRT - http://stks.co/3grp
about 24 days ago by greatstockpix
about 24 days ago by greatstockpix
Cantor Fitzgerald Maintains a 'Hold' on Hologic (HOLX); Acquisition Overshadows Challenging Quarter
May 01, 12:51PM Street Insider
May 01, 12:51PM Street Insider
Dougherty & Co Downgrades Hologic (HOLX) to Neutral; Four Reasons Not To Like The Deal
May 01, 10:28AM Street Insider
May 01, 10:28AM Street Insider
Needham & Company Maintains a 'Buy' on Hologic (HOLX); Qtr In-line; Acquisition on Gen-Probe is Transformational
May 01, 7:48AM Street Insider
May 01, 7:48AM Street Insider
$HOLX forms bearish "Diamond Top" chart pattern. http://stks.co/3aqb
about 29 days ago by RecogniaEvents
about 29 days ago by RecogniaEvents
GARP Research Maintains a 'Buy' on Conceptus (CPTS); Very Attractive Name in Health Care
Apr 30, 3:49PM Street Insider
Apr 30, 3:49PM Street Insider
#Hologic $HOLX to acquire Gen-Probe for about $3.72B in cash : http://stks.co/3aOH Quote http://stks.co/3aOI
about 30 days ago by TMXmoney
about 30 days ago by TMXmoney
RT @adamfeuerstein $HOLX acquiring $GPRO for $82.75 per share in cash. $3.7B deal.
about 30 days ago by StockTwits
about 30 days ago by StockTwits
Hologi $HOLX to acquire Gen-Probe $GPRO for $82.75 per share in cash, or a total enterprise value of approximately $3.7 billion.
about 30 days ago by Street_Insider
about 30 days ago by Street_Insider
$HOLX Hologic to Acquire Gen-Probe $GPRO - $SQNM could be bought out next i guess $ILMN ROCHE ?
about 30 days ago by biotech
about 30 days ago by biotech
$HOLX Hope those earnings are good, we need it back on an upward track
about 37 days ago by Bobsmith7
about 37 days ago by Bobsmith7
Hologic to Release Second Quarter Fiscal 2012 Operating Results on Monday, April 30, 2012
Apr 02, 7:00AM PR Newswire
Apr 02, 7:00AM PR Newswire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| HOLX | 16.99 | +0.07 | +0.41% | 4.463B |
| HOLL | 1.24 | +0.00 | +0.00% | 28.74M |
| HOLI | 9.57 | +0.41 | +4.48% | 511.40M |
| HOKU | 0.0833 | -0.01 | -9.06% | 5.030M |
| HOGS | 9.74 | +0.25 | +2.63% | 356.06M |
| HOG | 48.49 | +0.97 | +2.04% | 10.94B |
| HOFT | 11.43 | -0.31 | -2.64% | 126.67M |
| HNZ | 53.59 | +0.09 | +0.17% | 17.11B |
| HNT | 26.69 | +0.25 | +0.95% | 2.190B |
| HNRG | 7.36 | +0.17 | +2.36% | 203.55M |
